ARTICLE | Company News
EU marketing agreement for MediGene
April 5, 2001 7:00 AM UTC
Atrix Laboratories (ATRX) granted MediGene (NMarkt:MDG) exclusive European marketing rights for Leuprogel leuprolide to treat prostate cancer in one, three and four month preparations. MDG will provid...